These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30255665)

  • 1. Molecular identification and antifungal susceptibility of clinical fungal isolates from onychomycosis (uncommon and emerging species).
    Haghani I; Shams-Ghahfarokhi M; Dalimi Asl A; Shokohi T; Hedayati MT
    Mycoses; 2019 Feb; 62(2):128-143. PubMed ID: 30255665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates.
    Baghi N; Shokohi T; Badali H; Makimura K; Rezaei-Matehkolaei A; Abdollahi M; Didehdar M; Haghani I; Abastabar M
    Med Mycol; 2016 Oct; 54(7):757-63. PubMed ID: 27118804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran.
    Ansari S; Hedayati MT; Zomorodian K; Pakshir K; Badali H; Rafiei A; Ravandeh M; Seyedmousavi S
    Mycopathologia; 2016 Feb; 181(1-2):89-95. PubMed ID: 26369643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular identification and antifungal susceptibility among clinical isolates of dermatophytes in Shiraz, Iran (2017-2019).
    Zareshahrabadi Z; Totonchi A; Rezaei-Matehkolaei A; Ilkit M; Ghahartars M; Arastehfar A; Motamedi M; Nouraei H; Sharifi Lari M; Mohammadi T; Zomorodian K
    Mycoses; 2021 Apr; 64(4):385-393. PubMed ID: 33295089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
    Carrillo-Muñoz AJ; Giusiano G; Guarro J; Quindós G; Guardia C; del Valle O; Rodríguez V; Estivill D; Cárdenes CD
    Int J Antimicrob Agents; 2007 Aug; 30(2):157-61. PubMed ID: 17555945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates.
    Salehi Z; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1841-1846. PubMed ID: 29980898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis.
    Wiederhold NP; Fothergill AW; McCarthy DI; Tavakkol A
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3553-5. PubMed ID: 24709260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
    Carrillo-Muñoz AJ; Giusiano G; Cárdenes D; Hernández-Molina JM; Eraso E; Quindós G; Guardia C; del Valle O; Tur-Tur C; Guarro J
    Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a polymerase chain reaction-restriction fragment length polymorphism assay for dermatophyte and nondermatophyte identification in onychomycosis.
    Bontems O; Hauser PM; Monod M
    Br J Dermatol; 2009 Oct; 161(4):791-6. PubMed ID: 19558597
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Rezaei-Matehkolaei A; Khodavaisy S; Alshahni MM; Tamura T; Satoh K; Abastabar M; Shokoohi GR; Ahmadi B; Kord M; Taghipour S; Makimura K; Badali H
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of phenotypically non-dermatophyte, non-Aspergillus filamentous fungi causing nail infections: importance of accurate identification and antifungal susceptibility testing.
    Tsang CC; Tang JYM; Chan KF; Lee CY; Chan JFW; Ngan AHY; Cheung M; Lau ECL; Li X; Ng RHY; Lai CKC; Fung KSC; Lau SKP; Woo PCY
    Emerg Microbes Infect; 2019; 8(1):531-541. PubMed ID: 30938262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of sertaconazole against dermatophyte isolates with reduced fluconazole susceptibility.
    Carrillo-Muñoz AJ; Fernández-Torres B; Cárdenes DC; Guarro J
    Chemotherapy; 2003 Sep; 49(5):248-51. PubMed ID: 14504436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
    Jo Siu WJ; Tatsumi Y; Senda H; Pillai R; Nakamura T; Sone D; Fothergill A
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1610-6. PubMed ID: 23318803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum-equiseti species complexes from onychomycosis in north of Iran.
    Haghani I; Shams-Ghahfarokhi M; Dalimi Asl A; Shokohi T; Hedayati MT
    Mycoses; 2022 Nov; 65(11):1030-1039. PubMed ID: 35775829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.
    Gupta C; Jongman M; Das S; Snehaa K; Bhattacharya SN; Seyedmousavi S; van Diepeningen AD
    Mycopathologia; 2016 Aug; 181(7-8):497-504. PubMed ID: 27138574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Mycological and Molecular Epidemiologic Study on Onychomycosis and Determination
    Halvaee S; Daie-Ghazvini R; Hashemi SJ; Khodavaisy S; Rahimi-Foroushani A; Bakhshi H; Rafat Z; Ardi P; Abastabar M; Zareei M; Borjian-Boroujeni Z; Kamali Sarvestani H
    Front Cell Infect Microbiol; 2021; 11():693522. PubMed ID: 34336717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Identification of Candida Species Isolated from Onychomycosis in Shanghai, China.
    Feng X; Ling B; Yang X; Liao W; Pan W; Yao Z
    Mycopathologia; 2015 Dec; 180(5-6):365-71. PubMed ID: 26227864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal activity of ME1111, a new topical agent for onychomycosis, against clinical isolates of dermatophytes.
    Ghannoum M; Isham N; Long L
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5154-8. PubMed ID: 26055386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, type and treatment of fungal pathogens in toenail onychomycosis in the central Alpine region of South Tyrol, northern Italy - a 10-year retrospective study from 2004 to 2013.
    Gasser J; Pagani E; Vittadello F; Nobile C; Zampieri P; Eisendle K
    Mycoses; 2016 Dec; 59(12):760-764. PubMed ID: 27402300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.